Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
4(50%)
Results Posted
100%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
1
13%
Ph phase_3
1
13%
Ph not_applicable
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Active, not recruiting3
Completed1
Terminated1
unknown1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

completed113%
active_not_recruiting338%
terminated113%
unknown113%
not_yet_recruiting113%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8